MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

222 hedge funds and large institutions have $3.36B invested in Madrigal Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 77 increasing their positions, 54 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
+34
Holders Change %
+18.09%
% of All Funds
3.55%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.16%
New
69
Increased
77
Reduced
54
Closed
34
Calls
$385M
Puts
$149M
Net Calls
+$235M
Net Calls Change
+$402M

Top Buyers

1
Marshall Wace
Marshall Wace
United Kingdom
$131M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$125M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$91M
4
Renaissance Technologies
Renaissance Technologies
New York
$42.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
$344M

Top Sellers

1
State Street
State Street
Massachusetts
$126M
2
APM
Avidity Partners Management
Texas
$0
3
LC
L1 Capital
Australia
$0
4
TCM
TCG Crossover Management
California
$36.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
$6.04M
Name Holding Trade Value Shares
Change 		Shares
Change %
EE
251
EWG Elevate
California
– -$145K -500 Closed
Balyasny Asset Management
252
Balyasny Asset Management
Illinois
– -$58.1K -200 Closed
AWM
253
Accurate Wealth Management
Florida
– -$8.95K -30 Closed
LC
254
Lindbrook Capital
California
– -$7.26K -25 Closed
CS
255
Comerica Securities
Michigan
– -$2.03K -7 Closed
BIA
256
Bell Investment Advisors
California
– -$1.45K -5 Closed
7 8 9 10
11